Pileri S - Search Results

1

Expression of the CD30 antigen in non-lymphoid tissues and cells.

Dürkop H, Foss HD, Eitelbach F, Anagnostopoulos I, Latza U, Pileri S, Stein H. Dürkop H, et al. Among authors: pileri s. J Pathol. 2000 Apr;190(5):613-8. doi: 10.1002/(SICI)1096-9896(200004)190:5<613::AID-PATH559>3.0.CO;2-0. J Pathol. 2000. PMID: 10727988

2

Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells.

Marafioti T, Hummel M, Anagnostopoulos I, Foss HD, Falini B, Delsol G, Isaacson PG, Pileri S, Stein H. Marafioti T, et al. Among authors: pileri s. N Engl J Med. 1997 Aug 14;337(7):453-8. doi: 10.1056/NEJM199708143370703. N Engl J Med. 1997. PMID: 9250847 Free article.

3

CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Stein H, Foss HD, Dürkop H, Marafioti T, Delsol G, Pulford K, Pileri S, Falini B. Stein H, et al. Among authors: pileri s. Blood. 2000 Dec 1;96(12):3681-95. Blood. 2000. PMID: 11090048 Free article. Review.

4

BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope.

Schwarting R, Gerdes J, Dürkop H, Falini B, Pileri S, Stein H. Schwarting R, et al. Among authors: pileri s. Blood. 1989 Oct;74(5):1678-89. Blood. 1989. PMID: 2477085 Free article.

5

Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype.

Herbst H, Tippelmann G, Anagnostopoulos I, Gerdes J, Schwarting R, Boehm T, Pileri S, Jones DB, Stein H. Herbst H, et al. Among authors: pileri s. Leuk Res. 1989;13(2):103-16. doi: 10.1016/0145-2126(89)90134-3. Leuk Res. 1989. PMID: 2538681

6

PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.

Falini B, Flenghi L, Pileri S, Gambacorta M, Bigerna B, Durkop H, Eitelbach F, Thiele J, Pacini R, Cavaliere A, et al. Falini B, et al. Among authors: pileri s. Am J Pathol. 1993 May;142(5):1359-72. Am J Pathol. 1993. PMID: 7684194 Free PMC article.

7

Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.

Pilozzi E, Pulford K, Jones M, Müller-Hermelink HK, Falini B, Ralfkiaer E, Pileri S, Pezzella F, De Wolf-Peeters C, Arber D, Stein H, Mason D, Gatter K. Pilozzi E, et al. Among authors: pileri s. J Pathol. 1998 Oct;186(2):140-3. doi: 10.1002/(SICI)1096-9896(1998100)186:2<140::AID-PATH149>3.0.CO;2-Y. J Pathol. 1998. PMID: 9924428

8

Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies.

Falini B, Pileri S, Stein H, Dieneman D, Dallenbach F, Delsol G, Minelli O, Poggi S, Martelli MF, Pallesen G, et al. Falini B, et al. Among authors: pileri s. Hum Pathol. 1990 Jun;21(6):624-9. doi: 10.1016/s0046-8177(96)90009-x. Hum Pathol. 1990. PMID: 1693592

9

Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells.

Hummel M, Ziemann K, Lammert H, Pileri S, Sabattini E, Stein H. Hummel M, et al. Among authors: pileri s. N Engl J Med. 1995 Oct 5;333(14):901-6. doi: 10.1056/NEJM199510053331403. N Engl J Med. 1995. PMID: 7545266 Free article.

10

CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.

Falini B, Pileri S, Pizzolo G, Dürkop H, Flenghi L, Stirpe F, Martelli MF, Stein H. Falini B, et al. Among authors: pileri s. Blood. 1995 Jan 1;85(1):1-14. Blood. 1995. PMID: 7803786 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

733 results

Search Page